An autoimmune disorder mainly affecting young adults and characterized by destruction
of myelin in the central nervous system. Pathologic findings include multiple sharply
demarcated areas of demyelination throughout the white matter of the central nervous
system. Clinical manifestations include visual loss, extra-ocular movement disorders,
paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder
dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery
(see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive
forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles
of Neurology, 6th ed, p903)
Qualificatifs autorisés : DI / PS / IM / MI / DG / PP / RH / EN / ET / MO / EP / BL
/ CF / CI / CN / DH / DT / TH / PX / UR / VI / VE / HI / CL / EC / EM / GE / NU /
RT / EH / PC / PA / ME / CO / SU
Informations sur la notice
Identifiant de la notice : 040743306
RCR créateur de la notice : 0001
Date de création : 23-09-1998
RCR dernier modificateur de la notice : 1999
Date de dernière modification : 20-03-2024 à 17 h 12